Content about Branded

LOS ANGELES — Rx Timer Cap has introduced a new version of the cap designed for ease of use among elderly patients.

The company announced Tuesday the introduction of the new EZ-Twist removal system for making the cap easy to open and close for people who don't require childproof caps.

ALLEGAN, Mich. — Perrigo chairman, CEO and president Joe Papa on Friday shared with analysts that private label OTCs are trending strong and that growth will be sustained going forward with the number of projected Rx-to-OTCs on the horizon. 

DEERFIELD, Ill. — Walgreens on Monday made available a new application programming interface that allows third-party mobile app developers to integrate the drug store chain’s prescription refill technology. Developers who have scanning functionality within their apps can easily integrate the API to enable their users to order a prescription refill by scanning the bar code on a Walgreens prescription bottle.

MOUNTAIN VIEW, Calif. — Patients who take a drug for losing weight may experience improvement in multiple cardiovascular disease risk factors, according to a new study.

WASHINGTON — Most Americans who reported getting a flu shot in the past season received that vaccination in their physician's office. However, about 20% received their flu shot at a retail pharmacy and 12.6% at a walk-in clinic, according to an Ipsos Public Affairs poll released Friday. That suggests that as many as 18.5 million flu shots were administered to adults at retail pharmacy and another 11.7 million to adults at walk-in clinics. 

WALNUT CREEK, Calif. — Aetna is offering individual health insurance plans to Costco members in California, the health insurer said.

The Costco Personal Health Insurance program includes five plans and offers broad medical benefits, dental options and a large network of doctors and hospitals. The program also is available to members of the club retailer in Arizona, Connecticut, Georgia, Illinois, Michigan, Nevada, Pennsylvania, Texas and Virginia. Aetna plans to expand the program to other markets in the coming months.

INDIANAPOLIS — Eli Lilly and Company on Tuesday reported that its fourth quarter revenue for the period ended Dec. 31 declined 1% to $6 billion because of its Zyprexa patent expiration. Full-year 2012 revenue declined 7% to $22.6 billion.

BRIDGEWATER, N.J. — Sanofi announced today that Auvi-Q (epinephrine injection, USP) is now available in U.S. retail pharmacies nationwide with a prescription from a healthcare provider.

NEW YORK — The Food and Drug Administration has approved a new use for a pneumococcal vaccine made by Pfizer, the drug maker said.

Pfizer announced the approval of Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) for children and adolescents ages 6 years to 17 years for active immunization against the 13 Streptococcus pneumonia serotypes the vaccine covers. For this group, Prevnar 13 is administered as a one-time dose to patients who have never received it.

ATLANTA — If the flu were a storm cloud, the influenza virus is hovering over America's Bread Basket on its way to the Southwest, according to data provided through the U.S. Outpatient Influenza-like Illness Surveillance Network. 

The Centers for Disease Control and Prevention on Friday reported that 4.3% of patient visits reported through ILINet were due to influenza-like illness, above the national baseline of 2.2%. But as the map indicates, influenza rates are declining up and down the East Coast and is most virulent in Texas and states west.

BALTIMORE — "Too sick to go to work, but not sick enough not to tweet about it" Twitter users are helping to predict flu trends. Johns Hopkins researchers recently created a Twitter search method that helps differentiate between people merely tweeting about the flu in general and those who are actually sick, the university announced Thursday. The new tweet-screening method not only delivers real-time data on flu cases, but also filters out online chatter that is not linked to actual flu infections. 

WASHINGTON — A division of drug maker Teva Pharmaceutical Industries is partnering with an advocacy group focused on asthma in the launch of a new educational website about the condition.

The Asthma and Allergy Foundation of America and Teva Respiratory announced the launch of Get Smart About Asthma, which aims to increase understanding of how inflammation in the airways contributes to the disease's persistence and severity, as well as providing other educational materials.